interferon
ifn
long
histori
type
ifn
first
discov
factor
interfer
viral
replic
type
ii
ifn
identifi
year
later
molecul
secret
activ
lymphocyt
respons
antigen
stimul
yet
third
type
ifn
also
capabl
interf
viral
infect
term
type
iii
ifn
lambda
ifn
describ
rais
new
question
natur
need
three
ifn
system
new
challeng
specif
role
type
ifn
fulfil
type
iii
ifn
compris
four
member
human
two
mice
comparison
type
ifn
human
mammal
encod
thirteen
differ
gene
sever
distantli
relat
gene
pseudogen
singl
gene
type
ii
ifn
consist
one
gene
type
iii
ifn
signal
uniqu
heterodimer
receptor
complex
compris
ifnlra
confer
ligand
specif
also
share
famili
member
requir
signal
type
ifn
signal
though
notabl
ifn
share
uniqu
abil
activ
larg
set
gene
collect
known
interferonstimul
gene
isg
inhibit
viral
replic
degrad
viral
nucleic
acid
induc
viral
resist
neighbor
cell
mani
isg
known
inhibit
bacteri
parasit
infect
well
place
ifn
center
stage
antimicrobi
immun
mammal
among
variou
ifn
type
ifn
long
consid
constitut
primari
antivir
antibacteri
defens
mechan
bodi
produc
almost
cell
type
upon
infect
signal
almost
cell
type
confer
protect
contrast
share
ubiquit
pattern
express
rather
express
restrict
nk
cell
cell
engag
later
antimicrobi
immun
respons
follow
product
type
ifn
innat
inflammatori
cue
involv
strengthen
type
ifnmedi
defens
regul
adapt
immun
howev
discoveri
type
iii
ifn
exhibit
analog
activ
express
pattern
type
ifn
complic
paradigm
lead
suggest
type
iii
ifn
may
import
first
line
defens
barrier
surfac
respiratori
gastrointestin
urogenit
tract
review
current
literatur
implic
type
iii
ifn
refer
throughout
regul
immun
homeostasi
respiratori
tract
highlight
uniqu
antivir
immun
modulatori
function
share
type
ifn
discuss
two
appar
similar
ifn
system
need
optim
host
protect
induc
respons
divers
pathogen
includ
dna
rna
virus
well
intracellular
extracellular
bacteria
respiratori
tract
compris
influenza
virus
rhinovirus
respiratori
syncyti
virus
pneumonia
h
influenza
aureu
tuberculosi
trigger
high
level
multipl
pattern
recognit
receptor
ppr
involv
process
includ
endosom
tolllik
receptor
tlr
cytosol
sensor
rigi
recogn
doublestrand
singlestrand
rna
unmenthyl
dna
microbi
structur
pattern
recognit
receptor
abund
respiratori
epithelium
immun
cell
lie
beneath
epitheli
layer
sampl
airway
lumen
resid
lung
parenchyma
convent
plasmacytoid
dendrit
cell
dc
alveolar
interstiti
macrophag
monocyt
interestingli
although
cell
broadli
respond
prr
engag
express
select
specif
cell
type
promin
epitheli
cell
dc
suggest
involv
addit
epigenet
transcript
posttranscript
regul
determin
abil
cell
make
inde
rigilik
receptor
signal
via
mitochrondri
antivir
signal
protein
peroxisom
presenc
transcript
repressor
may
provid
signal
control
express
surpris
observ
sinc
earli
day
discoveri
abil
activ
remark
similar
downstream
signal
cascad
type
ifn
despit
util
distinct
receptor
complex
type
ifn
trigger
jakstat
pathway
lead
phosphoryl
nuclear
transloc
stat
activ
interferonregulatori
factor
format
transcript
complex
ifnstimul
gene
factor
critic
involv
induct
isg
even
direct
sidebysid
comparison
cultur
cell
difficult
distinguish
type
type
iii
ifn
respons
therefor
propos
cytokin
share
antivir
activ
inde
numer
vitro
vivo
studi
shown
effect
type
ifn
treat
viral
bacteri
infect
effort
explain
organ
employ
two
function
ifn
system
similar
activ
confront
infect
idea
ligand
avail
propos
base
notion
uniqu
infect
induc
specif
set
ifn
accordingli
determin
respons
although
import
ligandcentr
view
fit
mani
situat
type
type
iii
ifn
induc
concept
compartment
therefor
put
forward
suggest
type
iii
ifn
may
import
barrier
surfac
gastrointestin
epitheli
layer
type
ifn
may
predomin
barrier
surfac
breach
underli
tissu
circul
support
exhibit
restrict
pattern
express
compar
type
ifn
receptor
whose
presenc
ubiquit
primarili
found
epitheli
origin
cell
although
leukocyt
neutrophil
also
express
evid
compartment
come
recent
work
intestin
pathogen
indic
suffic
clear
murin
rotaviru
reoviru
noroviru
infect
intestin
epithelium
type
ifn
import
prevent
viral
spread
lamina
propria
andor
system
dissemin
still
compartment
alon
may
suffic
explain
util
two
ifn
system
one
report
particular
suggest
dispens
role
type
type
iii
ifn
murin
rotaviru
infect
gastrointestin
tract
tempor
requir
type
iii
ifn
protect
simian
rotaviru
infect
moreov
respiratori
track
clearcut
compartment
exist
rather
appear
type
ifn
exhibit
distinct
function
activ
start
emerg
respiratori
tract
among
site
bodi
type
iii
ifn
abundantli
express
primari
target
respiratori
pathogen
influenza
virus
rhinovirus
nose
tracheal
epithelium
upper
respiratori
tract
lower
airway
epithelium
lung
parenchyma
also
reach
accordingli
primari
nose
airway
epitheli
cell
bronchial
alveolar
epitheli
cell
line
express
high
level
follow
infect
cultur
howev
smooth
muscl
cell
fibroblast
immun
cell
convent
plasmacytoid
dc
also
express
suggest
epitheli
barrier
breach
addit
sourc
product
exist
type
ifn
also
induc
respiratori
pathogen
respiratori
epitheli
cell
express
subtyp
primarili
produc
immun
cell
smooth
muscl
cell
fibroblast
also
make
numer
studi
year
demonstr
key
import
type
ifn
provid
antivir
protect
influenza
parainfluenza
virus
rhinovirus
respiratori
syncyti
virus
adenovirus
other
anim
particular
shown
particularli
suscept
infect
recombin
type
ifn
treatment
shown
prevent
infect
therefor
consid
secondari
import
till
recent
although
initi
studi
mice
shown
predomin
ifn
produc
respons
infect
anim
suscept
influenza
viru
infect
compar
anim
specif
nonredund
function
mice
could
describ
induc
isg
type
ifn
also
activ
nk
cell
overexpress
endogen
product
seem
requir
optim
nk
cell
activ
effect
indirect
nk
cell
express
addit
type
ifn
direct
potent
activ
nk
cell
yet
recent
refin
studi
start
uncov
uniqu
role
substitut
type
ifn
shown
primari
earlier
ifn
induc
follow
viral
infect
confer
viral
resist
respiratori
mucosa
limit
initi
viral
spread
viral
load
low
suffic
confront
infect
howev
viral
load
high
first
place
escap
control
type
ifn
trigger
order
enhanc
organ
antivir
defens
accordingli
anim
exhibit
markedli
enhanc
viral
burden
follow
infect
low
viral
load
upregul
type
ifn
level
highlight
essenti
role
play
process
figur
central
antivir
protect
respiratori
epithelium
site
first
induc
primarili
act
limit
initi
viral
spread
howev
neutrophil
also
import
express
high
level
respond
signal
deal
uptaken
viral
load
prevent
viru
infect
neighbor
epitheli
cell
beyond
time
compon
studi
also
uncov
fundament
function
differ
type
demonstr
although
type
ifn
trigger
robust
proinflammatori
respons
character
upregul
divers
cytokin
chemokin
includ
tnf
lack
function
induc
express
isg
without
affect
product
inflammatori
mediat
accordingli
recombin
administr
experiment
anim
suppress
immunoinflammatori
cascad
trigger
respiratori
viral
infect
wherea
exert
opposit
effect
interestingli
express
isg
trigger
follow
slower
prolong
kinet
compar
type
ifn
induc
faster
transient
express
isg
central
antivir
andor
proinflammatori
activ
type
ifn
neutrophil
constitut
predomin
leukocyt
mediat
initi
antimicrobi
immun
secret
cytokin
chemokin
earli
infect
although
neutrophil
respond
ifn
augment
antivir
defens
exhibit
proinflammatori
activ
respons
type
ifn
find
await
confirm
human
also
directli
affect
neutrophil
proinflammatori
function
mice
human
suppress
reactiv
oxygen
speci
product
degranul
neutrophil
therebi
limit
tissu
damag
function
preserv
barrier
integr
teleolog
make
sens
increas
proinflammatori
respons
need
optim
protect
viral
infect
howev
also
caus
increas
tissu
damag
impair
respiratori
function
diseas
symptom
therefor
trigger
unnecessarili
line
emerg
paradigm
schemat
shown
figur
place
type
ifn
second
line
defens
deal
respiratori
infect
escap
control
expens
though
host
fit
research
mostli
focus
role
infect
constitut
primari
trigger
express
vitro
vivo
yet
demonstr
set
chronic
inflamm
also
induc
independ
infecti
insult
possibl
action
cytokin
inflammatori
environment
cue
thu
develop
allerg
airway
inflamm
mice
signific
level
detect
bronchoalveolar
lavag
anim
shown
requir
reduc
inflammatori
burden
lung
keep
allerg
airway
diseas
aad
control
accordingli
mice
exhibit
markedli
worsen
aad
wildtyp
anim
treat
intranas
recombin
demonstr
significantli
reduc
type
inflamm
amelior
diseas
although
molecular
detail
mechan
involv
remain
incomplet
understood
involv
signal
lung
convent
dc
suppress
respons
induct
interestingli
increas
mrna
level
detect
sputum
asthmat
patient
compar
healthi
individu
absenc
evid
viral
infect
shown
correl
patient
milder
asthma
symptom
suggest
may
also
exhibit
similar
protect
activ
human
diseas
well
steadyst
product
appear
therefor
key
keep
inflamm
asthma
control
reduc
diseas
symptom
figur
effect
respons
limit
set
aad
may
wider
import
suppress
develop
primari
immun
respons
vivo
well
also
inhibit
respons
vitro
human
cell
reduct
possibl
increas
remain
clarifi
though
exactli
mediat
effect
consensu
cell
directli
respond
induc
isg
signatur
tag
type
iii
ifn
signal
contrari
convent
dc
plasmacytoid
dc
either
human
mous
origin
shown
sever
studi
upregul
isg
alter
function
upon
stimul
howev
even
case
situat
crystal
clear
also
report
convent
plasmacytoid
dc
respond
possibl
reflect
differ
origin
eg
spleen
vs
bone
marrow
blood
cultur
differenti
protocol
cytokin
environ
eg
presenc
gmcsf
comprehens
studi
address
respons
variou
dc
popul
subpopul
therefor
urgent
need
noteworthi
shown
induc
prolifer
regulatori
cell
vitro
confirm
find
vivo
still
await
also
particularli
import
asthma
exacerb
induct
type
type
iii
ifn
follow
viral
infect
defici
allerg
asthmat
patient
poorli
control
asthma
either
strongli
environ
respiratori
mucosa
use
corticosteroid
gener
suppress
ifn
product
function
eg
induct
epigenet
chang
prevent
optim
gene
express
translat
either
case
render
allerg
asthmat
patient
distinctli
suscept
viral
exacerb
asthma
main
caus
hospit
lifethreaten
situat
diseas
exacerb
character
sudden
upregul
epithelialderiv
cytokin
rapid
aggrav
type
respons
airway
regul
type
type
iii
ifn
figur
inde
phase
ii
clinic
studi
administ
inhal
rang
asthmat
patient
moder
sever
asthma
demonstr
signific
improv
difficult
treat
group
patient
highlight
potenti
benefit
approach
although
treatment
overal
well
toler
longknown
advers
effect
type
ifn
fever
diarrhea
flulik
diseas
still
issu
concern
therefor
current
consid
better
altern
type
ifn
treat
asthma
exacerb
exhibit
reduc
advers
effect
safer
pharmacolog
profil
defici
ifn
product
respiratori
epithelium
also
observ
chronic
obstruct
pulmonari
diseas
copd
anoth
diseas
character
frequent
viral
induc
exacerb
bronchial
epitheli
cell
copd
patient
capabl
mount
full
ifn
respons
upon
viral
infect
possibl
due
cigarett
smoke
exposur
bronchial
epitheli
cell
smoker
significantli
reduc
level
compar
nonsmok
administr
recombin
may
therefor
benefici
treatment
copd
exacerb
well
whether
also
import
steadi
state
stabl
diseas
whether
involv
chronic
respiratori
diseas
remain
investig
last
year
major
progress
understand
uniqu
function
share
type
ifn
taken
place
reveal
import
frontlin
antivir
defens
bodi
especi
respiratori
gastrointestin
tract
act
synergi
type
ifn
fine
tune
immun
optim
protect
minim
host
damag
also
uncov
signific
keep
inflamm
control
prevent
exacerb
asthma
support
potenti
use
treatment
divers
respiratori
diseas
despit
key
gap
knowledg
exist
thu
remain
larg
unexplor
whether
also
import
immun
bacteri
fungal
infect
respiratori
tract
barrier
surfac
gener
posit
comparison
type
ifn
also
remain
unclear
whether
import
adapt
immun
respons
infect
antibodi
cytotox
cell
respons
includ
immunolog
memori
well
known
affect
type
ifn
moreov
remain
establish
whether
import
chronic
respiratori
disord
beyond
asthma
copd
affect
cours
diseas
process
studi
toward
direct
therefor
urgent
need
highli
promis
therapeut
candid
effect
exploit
clinic
ea
ms
ig
ok
contribut
write
manuscript
ea
ok
design
graph
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
